Asenapine Patch Adhesive Layer Formulation for Permeability and Adhesion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional patches containing asenapine with a rubber-based adhesive agent face challenges in maintaining sufficient skin permeability and adhesion force, as the incorporation of asenapine and rubber-based adhesive agents can decrease the adhesion force of the adhesive layer.

Innovation Solution

A patch design incorporating free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent, specifically styrene-isoprene-styrene block copolymers or polyisobutylene, in the adhesive layer, which maintains a strong adhesion force while enhancing skin permeability and release of asenapine.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If asenapine and rubber-based adhesive agent are incorporated into the adhesive agent layer, then the skin permeability of asenapine is improved, but the adhesion force of the adhesive agent layer is decreased

Engineering Contradiction:
Improveskin permeability of asenapineVSAvoidadhesion force of adhesive agent layer
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent applies parameter changes by carefully controlling the content ratio of asenapine to rubber-based adhesive agent within 1:1 to 1:9 by mass, and maintaining asenapine content at 0.1-10% by mass in the adhesive agent layer. These specific parameter ranges optimize both skin permeability and adhesion force, resolving the contradiction between improved drug delivery and maintained adhesive strength.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If asenapine is released from the adhesive agent layer, then the plasma concentration of asenapine can be maintained at therapeutically effective level, but the adhesion force of the adhesive agent layer is decreased

Engineering Contradiction:
Improveplasma concentration of asenapineVSAvoidadhesion force of adhesive agent layer
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent resolves this contradiction by optimizing the release parameters through controlled asenapine content (0.1-10% by mass) and specific ratio to rubber-based adhesive agent (1:1 to 1:9). These parameter changes enable sufficient drug release for therapeutic plasma concentration while maintaining adequate adhesion force through the balanced formulation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The patch achieves a balance of strong adhesion and effective skin permeability of asenapine, preventing a decrease in adhesion force and ensuring therapeutic plasma concentrations, while minimizing skin irritation and local adverse effects.

Implementation Method 1

the skin permeability of asenapine is not sufficient, so that it is difficult to keep the plasma concentration of asenapine at a therapeutically effective level

Methodology Applied
Scientific EffectSkin permeation: Permeation

Implementation Method 2

the adhesion force of an adhesive agent layer is decreased in the case where asenapine and the rubber-based adhesive agent are incorporated into the adhesive agent layer

Methodology Applied
Scientific EffectAdhesion: Adhesive

Data Source

PatentUS11813364B2Patch
Publication Date: 2023.11.14 HISAMITSU PHARM CO INC
  • US11813364B2 patent drawing

AI summary

In a patch comprising a support layer and an adhesive agent layer, the adhesive agent layer comprises free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent.